Elucidation of chemical background enhances interpretation of novel oligonucleotide drug impurities by mass spectrometry

Sample introduction into a mass spectrometer (MS) is associated with the likelihood of introducing background chemicals, which may form adducts with the analyte of interest such as oligonucleotide therapeutic drugs, significantly interfering with the interpretation of the MS data. Here we examine the variables affecting the formation of adducts. We found that most of the chemical species forming adducts are present in the carrier stream as impurities. Adduct formation is affected by experimental parameters but also depends on the oligonucleotide sequence. We introduce a novel and practical approach to identify unknown oligonucleotide adducts which includes tandem MS (MS/MS) interpretation and comparison of the accurate mass difference between the parent oligo and adduct, with the masses of the impurities in the chemical background. We give exhaustive examples of the steps in the identification of 10 oligonucleotide adducts. Knowledge about the unwanted interactions of analytes of interest with extraneous chemical entities can increase the accuracy of MS-based interpretations and conclusions and is of interest to all areas of MS applications.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-77146-9
Primary Topic
Mass Spectrometry Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Elucidation of chemical background enhances interpretation of novel oligonucleotide drug impurities by mass spectrometry

Claus Rentel, Stilianos G. Roussis, Kym Bradley
2 links
Scientific Reports
Mass Spectrometry Techniques and Applications
article

Elucidation of chemical background enhances interpretation of novel oligonucleotide drug impurities by mass spectrometry

Claus Rentel, Stilianos G. Roussis, Kym Bradley
article en

Abstract

Sample introduction into a mass spectrometer (MS) is associated with the likelihood of introducing background chemicals, which may form adducts with the analyte of interest such as oligonucleotide therapeutic drugs, significantly interfering with the interpretation of the MS data. Here we examine the variables affecting the formation of adducts. We found that most of the chemical species forming adducts are present in the carrier stream as impurities. Adduct formation is affected by experimental parameters but also depends on the oligonucleotide sequence. We introduce a novel and practical approach to identify unknown oligonucleotide adducts which includes tandem MS (MS/MS) interpretation and comparison of the accurate mass difference between the parent oligo and adduct, with the masses of the impurities in the chemical background. We give exhaustive examples of the steps in the identification of 10 oligonucleotide adducts. Knowledge about the unwanted interactions of analytes of interest with extraneous chemical entities can increase the accuracy of MS-based interpretations and conclusions and is of interest to all areas of MS applications.

Scientific ReportsVol. 16(1)
Ionis Pharmaceuticals (United States) (US)
Mass Spectrometry Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon